An expansion of an ongoing outpatient clinical trial, the study now includes metformin, fluvoxamine and ivermectin as possible treatments of COVID-19 and to prevent “long COVID” An ongoing COVID-19 clinical trial studying the outpatient use of metformin, a generic medication for type 2 diabetes, has expanded and will now be the ...